Acrospire Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-800
| Closed | -$97K | – | 1729 |
|
|
2017
Q2 | $97K | Sell |
800
-500
| -38% | -$60.6K | 0.09% | 271 |
|
|
2017
Q1 | $158K | Sell |
1,300
-1,100
| -46% | -$134K | 0.13% | 103 |
|
|
2016
Q4 | $294K | Buy |
2,400
+1,200
| +100% | +$147K | 0.12% | 159 |
|
|
2016
Q3 | $147K | Buy |
1,200
+400
| +50% | +$49K | 0.1% | 286 |
|
|
2016
Q2 | $93K | Buy |
800
+300
| +60% | +$34.9K | 0.07% | 525 |
|
|
2016
Q1 | $70K | Buy |
+500
| New | +$70K | 0.05% | 632 |
|